• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非天然肽作为HLA - B*2705人类白细胞抗原高亲和力配体的合理设计。

Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen.

作者信息

Rognan D, Scapozza L, Folkers G, Daser A

机构信息

Department of Pharmacy, Swiss Federal Institute of Technology, Zürich.

出版信息

Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):753-7. doi: 10.1073/pnas.92.3.753.

DOI:10.1073/pnas.92.3.753
PMID:7846047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC42698/
Abstract

From the three-dimensional structure of the class I major histocompatibility complex (MHC) HLA-B*2705 protein, several nonnatural peptides were designed either to optimize the interactions of one peptide amino acid (position 3) with its HLA binding pocket (pocket D) or to simplify the T-cell receptor-binding part by substitution with organic spacers. The stability of each MHC-ligand complex was simulated by 150-ps molecular dynamics in a water environment and compared with that of the natural complexes. All peptides were synthesized and tested for binding to the class I MHC protein in an in vitro assembly assay. As predicted from the computed atomic fluctuations and buried surface areas of MHC-bound ligands, bulky hydrophobic side chains at position 3 enhance the binding of a nonameric peptide to the HLA-B27 protein. Furthermore, it was possible to simplify half of the peptide sequence (residues 4-8) by replacement with organic fragments without altering the affinity of the designed ligands for the class I MHC protein. This study constitutes an initial step toward the rational design of nonpeptide class I MHC ligands for use in the selective immunotherapy of autoimmune diseases associated with particular HLA alleles.

摘要

根据I类主要组织相容性复合体(MHC)HLA - B*2705蛋白的三维结构,设计了几种非天然肽,要么优化一种肽氨基酸(第3位)与其HLA结合口袋(口袋D)的相互作用,要么通过用有机间隔物替代来简化T细胞受体结合部分。在水环境中通过150皮秒的分子动力学模拟了每个MHC - 配体复合物的稳定性,并与天然复合物的稳定性进行了比较。所有肽均已合成,并在体外组装试验中测试了其与I类MHC蛋白的结合情况。正如从计算出的MHC结合配体的原子波动和埋藏表面积所预测的那样,第3位的庞大疏水侧链增强了九聚体肽与HLA - B27蛋白的结合。此外,通过用有机片段替代,可以简化一半的肽序列(第4 - 8位残基),而不会改变设计的配体对I类MHC蛋白的亲和力。这项研究是朝着合理设计用于与特定HLA等位基因相关的自身免疫性疾病的选择性免疫治疗的非肽I类MHC配体迈出的第一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e150/42698/9a2ec8ec9a15/pnas01481-0117-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e150/42698/9a2ec8ec9a15/pnas01481-0117-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e150/42698/9a2ec8ec9a15/pnas01481-0117-a.jpg

相似文献

1
Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen.非天然肽作为HLA - B*2705人类白细胞抗原高亲和力配体的合理设计。
Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):753-7. doi: 10.1073/pnas.92.3.753.
2
Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.含(R)-3-羟基丁酸酯和β-高丙氨酸低聚物的九肽类似物:合成及其与I类主要组织相容性复合体蛋白的结合亲和力
J Med Chem. 1999 Jul 1;42(13):2318-31. doi: 10.1021/jm981123l.
3
Structure-based design of nonnatural ligands for the HLA-B27 protein.
J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):645-57. doi: 10.3109/10799899909036677.
4
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2.患有脊椎关节病的大猩猩表达一种与HLA - B27仅有有限序列相似性的MHC I类分子,该分子在P2位置结合带有精氨酸的肽段。
J Immunol. 2001 Mar 1;166(5):3334-44. doi: 10.4049/jimmunol.166.5.3334.
5
Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.抗原与两个仅在单个氨基酸残基上存在差异的I类主要组织相容性蛋白(B*2705和B*2703)结合的精细特异性。
J Comput Aided Mol Des. 1997 Sep;11(5):463-78. doi: 10.1023/a:1007963901092.
6
Computational characterization of residue couplings and micropolymorphism-induced changes in the dynamics of two differentially disease-associated human MHC class-I alleles.计算残基偶联和微多态性诱导的两种差异疾病相关人类 MHC Ⅰ类等位基因动力学变化的特征。
J Biomol Struct Dyn. 2018 Feb;36(3):724-740. doi: 10.1080/07391102.2017.1295884. Epub 2017 Mar 1.
7
Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.用于预测非天然九肽与I类主要组织相容性复合体蛋白结合的分子动力学和基于结构的药物设计
Acta Crystallogr D Biol Crystallogr. 1995 Jul 1;51(Pt 4):541-9. doi: 10.1107/S0907444995002678.
8
Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes.
Biochemistry. 1994 Sep 27;33(38):11476-85. doi: 10.1021/bi00204a009.
9
Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.与HLA - B27结合肽库中同种异体反应性T细胞表位相关的肽的多样性有限,这是由加工 - 负载途径多个步骤的限制导致的。
J Immunol. 2000 Jan 1;164(1):329-37. doi: 10.4049/jimmunol.164.1.329.
10
Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705.
J Pept Sci. 1998 Sep;4(6):378-88. doi: 10.1002/(sici)1099-1387(199809)4:6<378::aid-psc157>3.0.co;2-b.

引用本文的文献

1
Fully synthetic macromolecular prodrug chemotherapeutics with EGFR targeting and controlled camptothecin release kinetics.具有表皮生长因子受体(EGFR)靶向性和可控喜树碱释放动力学的全合成大分子前药化疗药物。
Polym Chem. 2018 Nov 14;9(42):5224-5233. doi: 10.1039/c8py01047a. Epub 2018 Sep 25.
2
IntroSpect: Motif-Guided Immunopeptidome Database Building Tool to Improve the Sensitivity of HLA I Binding Peptide Identification by Mass Spectrometry.Introspect:基于基序的免疫肽组数据库构建工具,通过质谱提高 HLA I 结合肽鉴定的灵敏度。
Biomolecules. 2022 Apr 14;12(4):579. doi: 10.3390/biom12040579.
3
The Structure of a Peptide-Loaded Shark MHC Class I Molecule Reveals Features of the Binding between β-Microglobulin and H Chain Conserved in Evolution.

本文引用的文献

1
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.活抗原呈递细胞上改变的T细胞受体配体诱导T细胞无能
Nature. 1993 May 13;363(6425):156-9. doi: 10.1038/363156a0.
2
A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution.脊柱关节病中HLA - B27免疫失调的一种假说:肠道微生物、B27结构、与B27结合的肽以及趋同进化的作用
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9330-4. doi: 10.1073/pnas.90.20.9330.
3
Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding.
肽负载的鲨鱼 MHC I 类分子结构揭示了β-微球蛋白与 H 链之间结合的特征,这些特征在进化中是保守的。
J Immunol. 2021 Jul 1;207(1):308-321. doi: 10.4049/jimmunol.2001165. Epub 2021 Jun 18.
4
In-solution enrichment identifies peptide inhibitors of protein-protein interactions.溶液中富集鉴定蛋白-蛋白相互作用的肽抑制剂。
Nat Chem Biol. 2019 Apr;15(4):410-418. doi: 10.1038/s41589-019-0245-2. Epub 2019 Mar 18.
5
T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.使用分子动力学进行T细胞表位预测和免疫复合物模拟:现状与持续挑战
Immunome Res. 2010 Nov 3;6 Suppl 2(Suppl 2):S4. doi: 10.1186/1745-7580-6-S2-S4.
6
Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors.模拟肽-主要组织相容性复合体I类配体与其受体之间的相互作用。I. 两种αβ T细胞受体的识别
J Comput Aided Mol Des. 2000 Jan;14(1):53-69. doi: 10.1023/a:1008142830353.
7
Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.抗原与两个仅在单个氨基酸残基上存在差异的I类主要组织相容性蛋白(B*2705和B*2703)结合的精细特异性。
J Comput Aided Mol Des. 1997 Sep;11(5):463-78. doi: 10.1023/a:1007963901092.
8
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.由HLA - B*2705和B*2703等位基因变体呈递的内源性肽的差异。对脊柱关节病易感性的影响。
J Clin Invest. 1996 Dec 15;98(12):2764-70. doi: 10.1172/JCI119102.
9
Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.含有设计为延伸出HLA - A2结合位点的大聚乙二醇环的抗原肽与I类主要组织相容性复合体分子形成稳定复合物。
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4583-8. doi: 10.1073/pnas.93.10.4583.
肽锚定残基对I类主要组织相容性复合体分子结合作用的定量分析
J Biol Chem. 1993 Oct 5;268(28):21309-17.
4
Current perspectives in reactive arthritis.反应性关节炎的当前观点
Immunol Today. 1993 Aug;14(8):387-91. doi: 10.1016/0167-5699(93)90139-C.
5
Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.三种人类组织相容性抗原中P2特异性口袋的比较:HLA-A*6801、HLA-A*0201和HLA-B*2705
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8053-7. doi: 10.1073/pnas.90.17.8053.
6
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.刺激T细胞受体:由改变的肽配体激发的选择性T细胞功能
Immunol Today. 1993 Dec;14(12):602-9. doi: 10.1016/0167-5699(93)90200-5.
7
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.基于单个肽侧链独立结合对潜在HLA - A2结合肽进行排名的方案。
J Immunol. 1994 Jan 1;152(1):163-75.
8
Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.HLA-B*2702和B*2705肽基序中占主导地位的芳香族/脂肪族C末端锚定序列。
Immunogenetics. 1994;39(1):74-7. doi: 10.1007/BF00171803.
9
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.在体外和体内均未能证明存在长期的MHC饱和现象。对MHC阻断肽治疗潜力的影响。
J Immunol. 1994 May 1;152(9):4310-9.
10
A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis.一种经过合理设计的CD4类似物可抑制实验性变应性脑脊髓炎。
Nature. 1994 Apr 21;368(6473):744-6. doi: 10.1038/368744a0.